FATE THERAPEUTICS INC Quarterly Return On Equity in % from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fate Therapeutics Inc quarterly/annual Return On Equity history and growth rate from Q2 2014 to Q3 2024.
  • Fate Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was -45.9 %, a 19.4% decline year-over-year.
  • Fate Therapeutics Inc annual Return On Equity for 2023 was -38.2 %, a 25% increase from 2022.
  • Fate Therapeutics Inc annual Return On Equity for 2022 was -50.9 %, a 76.9% decline from 2021.
  • Fate Therapeutics Inc annual Return On Equity for 2021 was -28.8 %, a 37.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -45.9 -7.44 -19.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -44.1 +0.05 +0.11% Apr 1, 2024 Jun 30, 2024
Q1 2024 -46.5 -0.88 -1.93% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.2 +12.7 +25% Oct 1, 2023 Dec 31, 2023
Q3 2023 -38.4 +10.3 +21.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44.1 -5.45 -14.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.6 -12.3 -36.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -50.9 -22.1 -76.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.8 -19.2 -64.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38.7 -2.62 -7.26% Apr 1, 2022 Jun 30, 2022
Q1 2022 -33.3 +2.37 +6.64% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.8 +17.4 +37.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.6 +14 +32.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.1 +2.56 +6.63% Apr 1, 2021 Jun 30, 2021
Q1 2021 -35.7 +16.4 +31.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -46.2 +3.77 +7.55% Oct 1, 2020 Dec 31, 2020
Q3 2020 -43.6 +5.32 +10.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -38.6 +11.4 +22.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -52.1 +2.22 +4.09% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.9 +9.1 +15.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.9 +19.6 +28.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -50.1 +45 +47.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -54.3 +23 +29.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -59 +12 +16.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -68.6 -4.03 -6.25% Jul 1, 2018 Sep 30, 2018
Q2 2018 -95.1 -28.1 -41.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -77.3 -1.33 -1.75% Jan 1, 2018 Mar 31, 2018
Q4 2017 -71 +16.8 +19.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -64.5 +47.9 +42.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -67 +23.9 +26.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -75.9 -1.94 -2.62% Jan 1, 2017 Mar 31, 2017
Q4 2016 -87.8 -10.6 -13.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -112 -33.4 -42.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -90.9 -6.02 -7.09% Apr 1, 2016 Jun 30, 2016
Q1 2016 -74 +13.3 +15.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -77.2 -6.66 -9.44% Oct 1, 2015 Dec 31, 2015
Q3 2015 -79 -19 -31.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -84.9 +58.7 +40.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -87.2 Jan 1, 2015 Mar 31, 2015
Q4 2014 -70.6 Oct 1, 2014 Dec 31, 2014
Q3 2014 -60 Jul 1, 2014 Sep 30, 2014
Q2 2014 -144 Apr 1, 2014 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.